Treatment of ocular rosacea.

Edward J Wladis, Alejandro P Adam

Journal: Survey of ophthalmology 2018;63(3):340-346

PMID: 28782548

Full Text on Elsevier Science View on PubMed

Abstract

Although rosacea is a common entity with significant cosmetic, socioeconomic, and vision-threatening impacts, this disorder remains incurable. Furthermore, until quite recently many of the therapeutic options for rosacea had not been assessed through rigorous clinical testing with meaningful outcome measures. Nonetheless, new medical and surgical interventions that have been validated in well-designed trials hold the promise of treating rosacea more effectively. Furthermore, recent enhancements in our understanding of the cellular and molecular biology offer highly translational insights that will hopefully lead to the development of new treatment options for rosacea. We review the evidence for these therapies and discuss new scientific findings that can be exploited for new therapeutic interventions.

Address: Department of Ophthalmology, Ophthalmic Plastic Surgery, Lions Eye Institute, Albany Medical College, Slingerlands, New York, USA; Division of Otolaryngology, Department of Surgery, Albany Medical College, Slingerlands, New York, USA. Electronic address: [email protected].; Department of Molecular and Cellular Physiology, Albany Medical College, Slingerlands, New York, USA; Department of Ophthalmology, Lions Eye Institute, Albany Medical College, Slingerlands, New York, USA.

DOI: 10.1016/j.survophthal.2017.07.005

Link outs

Free resources

Medical:

https://medlineplus.gov/rosacea.html

Other Literature Sources:

Subscription / membership required

Full Text Sources:

MeSH Terms: Anti-Bacterial Agents, Corneal Diseases, Diet Therapy, Dry Eye Syndromes, Eyelid Diseases, Humans, Immunosuppressive Agents, Laser Therapy, Lubricant Eye Drops, Meibomian Glands, Ophthalmologic Surgical Procedures, Photophobia, Rosacea, Tears